The relationship between myocardial fibrosis detected by cardiac magnetic resonance and Tp-e interval, 5-year sudden cardiac death risk score in hypertrophic cardiomyopathy patients
- PMID: 31152489
- PMCID: PMC6931578
- DOI: 10.1111/anec.12672
The relationship between myocardial fibrosis detected by cardiac magnetic resonance and Tp-e interval, 5-year sudden cardiac death risk score in hypertrophic cardiomyopathy patients
Abstract
Background: The aim of this study was to investigate the relationship between QT (QTc) interval, Tp-e interval, Tp-e/QTc ratio, 5-year sudden cardiac death (SCD) risk score, and late gadolinium enhancement (LGE) detected by CMR in hypertrophic cardiomyopathy (HCM) patients.
Method: A total of 74 consecutive patients who underwent CMR with HCM diagnosis were included in the study. These patients were divided into two groups according to the presence of LGE on CMR. All patients underwent detailed echocardiography and QTc interval, Tp-e interval, and Tp-e/QTc ratios and 5-year SCD risk scores were calculated. These parameters were compared for two groups.
Results: CMR revealed LGE in 32 (43.2%) of 74 HCM patients. In the group with LGE, significantly higher QTc interval (p = 0.002), Tp-e interval (p < 0.001), Tp-e/QTc ratio (p = 0.004), and 5-year SCD risk score were detected. In addition, QTc interval, Tp-e interval, Tp-e/QTc ratio, maximum wall thickness, left ventricular mass index, 5-year SCD risk score, and cardiac fibrosis index were found to be correlated with various degrees in correlation analysis. Also, Tp-e interval is found to be an independent predictor of LGE detected by CMR in HCM patients (p = 0.017, OR [%95 CI] = 1.017 [1.001-1.034]). In addition, the Tp-e interval can detect the LGE with a sensitivity of 64.3% and a specificity of 84.2% at 99.4 ms. (p < 0.001, AUC [95% CI] = 0.790 [0.676-0.905]).
Conclusion: The Tp-e interval can be used to optimize SCD risk stratification in HCM patients and determine which patients will benefit from implantable cardioverter-defibrillator (ICD) treatment.
Keywords: Tp-e interval; cardiac magnetic resonance; hypertrophic cardiomyopathy; late gadolinium enhancement; sudden cardiac death.
© 2019 Wiley Periodicals, Inc.
Figures
Similar articles
-
The value of cardiac magnetic resonance and distribution of late gadolinium enhancement for risk stratification of sudden cardiac death in patients with hypertrophic cardiomyopathy.J Cardiol. 2016 Jul;68(1):49-56. doi: 10.1016/j.jjcc.2015.07.020. Epub 2015 Sep 9. J Cardiol. 2016. PMID: 26363820
-
ESC sudden-death risk model in hypertrophic cardiomyopathy: Incremental value of quantitative contrast-enhanced CMR in intermediate-risk patients.Clin Cardiol. 2017 Oct;40(10):853-860. doi: 10.1002/clc.22735. Epub 2017 Jun 14. Clin Cardiol. 2017. PMID: 28614597 Free PMC article.
-
Late Gadolinium Enhancement in Patients With Hypertrophic Cardiomyopathy and Preserved Systolic Function.J Am Coll Cardiol. 2018 Aug 21;72(8):857-870. doi: 10.1016/j.jacc.2018.05.060. J Am Coll Cardiol. 2018. PMID: 30115224
-
Prognostic Value of LGE-CMR in HCM: A Meta-Analysis.JACC Cardiovasc Imaging. 2016 Dec;9(12):1392-1402. doi: 10.1016/j.jcmg.2016.02.031. Epub 2016 Jul 20. JACC Cardiovasc Imaging. 2016. PMID: 27450876 Review.
-
Risk stratification using late gadolinium enhancement on cardiac magnetic resonance imaging in patients with hypertrophic cardiomyopathy: A systematic review and meta-analysis.Prog Cardiovasc Dis. 2021 May-Jun;66:10-16. doi: 10.1016/j.pcad.2020.11.001. Epub 2020 Nov 7. Prog Cardiovasc Dis. 2021. PMID: 33171204
Cited by
-
Ventricular Repolarization Dispersion is a Potential Risk for the Development of Life-Threatening Arrhythmia in Children with Hypertrophic Cardiomyopathy.Pediatr Cardiol. 2022 Oct;43(7):1455-1461. doi: 10.1007/s00246-022-02867-3. Epub 2022 Mar 13. Pediatr Cardiol. 2022. PMID: 35284943
-
Measurement of Early and Late Repolarization Periods in Addition to QT Interval to Help Predict the Torsadogenic Risk of Donepezil Based on Reverse Translational Animal Research on Its Proarrhythmic Potential - Reply.Circ Rep. 2021 Aug 6;3(9):556-557. doi: 10.1253/circrep.CR-21-0086. eCollection 2021 Sep 10. Circ Rep. 2021. PMID: 34568636 Free PMC article. No abstract available.
-
Association of electrocardiographic markers with myocardial fibrosis as assessed by cardiac magnetic resonance in different clinical settings.World J Cardiol. 2022 Sep 26;14(9):483-495. doi: 10.4330/wjc.v14.i9.483. World J Cardiol. 2022. PMID: 36187429 Free PMC article.
-
Association of QTc Interval and V4-S Wave With Appropriate ICD Therapy in Hypertrophic Cardiomyopathy.Front Cardiovasc Med. 2022 May 12;9:882662. doi: 10.3389/fcvm.2022.882662. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35647065 Free PMC article.
-
Impact of prolonged QTc interval on mortality risk with hypertrophic cardiomyopathy.J Arrhythm. 2024 Dec 2;41(1):e13199. doi: 10.1002/joa3.13199. eCollection 2025 Feb. J Arrhythm. 2024. PMID: 39817027 Free PMC article.
References
-
- Adabag, A. S. , Maron, B. J. , Appelbaum, E. , Harrigan, C. J. , Buros, J. L. , Gibson, C. M. , … Maron, M. S. (2008). Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. Journal of the American College of Cardiology, 51(14), 1369–1374. 10.1016/j.jacc.2007.11.071 - DOI - PubMed
-
- Akboğa, M. K. , Balcı, K. G. , Yılmaz, S. , Aydın, S. , Yayla, Ç. , Ertem, A. G. , Topaloğlu, S. (2017). Tp‐e interval and Tp‐e/QTc ratio as novel surrogate markers for prediction of ventricular arrhythmic events in hypertrophic cardiomyopathy. Anatolian Journal of Cardiology, 18(1), 48 10.14744/AnatolJCardiol.2017.7581. - DOI - PMC - PubMed
-
- Antzelevitch, C. , Sicouri, S. , Di Diego, J. M. , Burashnikov, A. , Viskin, S. , Shimizu, W. , … Zhang, L. I. (2007). Does Tpeak‐Tend provide an index of transmural dispersion of repolarization? Heart Rhythm: the Official Journal of the Heart Rhythm Society, 4(8), 1114–1116. 10.1016/j.hrthm.2007.05.028 - DOI - PMC - PubMed
-
- Bruder, O. , Wagner, A. , Jensen, C. J. , Schneider, S. , Ong, P. , Kispert, E.‐M. , … Mahrholdt, H. (2010). Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy. Journal of the American College of Cardiology, 56(11), 875–887. 10.1016/j.jacc.2010.05.007 - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources